Charles Carroll Financial Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$218K Sell
2,765
-1,700
-38% -$121K 0.23% 36
2023
Q3
$312K Buy
4,465
+515
+13% +$36.5K 0.39% 36
2023
Q2
$273K Buy
+3,950
New +$281K 0.35% 35
2022
Q2
Sell
-2,000
Closed -$202K 47
2022
Q1
$202K Hold
2,000
0.21% 39
2021
Q4
$206K Buy
+2,000
New +$185K 0.2% 37

Other funds holding CVS

Charles Carroll Financial Partners's CVS Position: Q4 2023 in Review

Charles Carroll Financial Partners reduced its CVS Health (CVS) stake by 38% in Q4 2023, selling an estimated $121K and leaving 2,765 shares worth $218K. The position accounts for 0.23% of the portfolio, ranked #36.

Charles Carroll Financial Partners first reported a position in CVS in Q4 2021 and has held it in 5 quarters since. The position peaked at $312K in Q3 2023. 2,258 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Charles Carroll Financial Partners held 2,765 shares of CVS Health worth $218K as of Q4 2023.
  • Charles Carroll Financial Partners sold 1,700 CVS Health shares in Q4 2023, an estimated $121K.
  • CVS Health made up 0.23% of Charles Carroll Financial Partners's portfolio in Q4 2023, its #36 holding.
  • Charles Carroll Financial Partners first reported a position in CVS Health in Q4 2021 and has held it in 5 quarters since.
  • Charles Carroll Financial Partners's CVS Health position peaked at $312K in Q3 2023.
  • 2,258 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Charles Carroll Financial Partners's 13F filing for Q4 2023, filed 6 Feb 2024.